Back to results
CompletedEARLY_Phase 1

Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.

NCT03197389

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University Hospitals Leuven

Leuven, Belgium

View on ClinicalTrials.gov